Diametric Capital, LP - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 256 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Diametric Capital, LP ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$950,000
+83.8%
18,110
+17.4%
0.73%
+16.1%
Q1 2020$517,000
-36.9%
15,430
-14.6%
0.63%
+4.8%
Q4 2019$819,000
+50.0%
18,073
+26.0%
0.60%
+32.9%
Q3 2019$546,000
-42.8%
14,339
-34.7%
0.45%
-25.7%
Q2 2019$955,00021,9480.61%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Tamarack Advisers, LP 550,000$18,442,0006.98%
Gagnon Advisors, LLC 193,860$6,500,0006.06%
GAGNON SECURITIES LLC 407,159$13,652,0004.64%
Spyglass Capital Management LLC 1,190,537$39,919,0004.51%
Paulson & Co. 1,716,727$57,562,0002.20%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,627,521$54,571,0001.73%
Elk Creek Partners, LLC 265,146$8,890,0001.53%
HealthCor Management, L.P. 887,370$29,754,0001.27%
Rock Springs Capital Management LP 900,000$30,177,0001.25%
Lisanti Capital Growth, LLC 108,679$3,644,0001.20%
View complete list of PACIRA PHARMACEUTICALS INC shareholders